Status:
COMPLETED
Micronutrient Supplementation in Children With ASD
Lead Sponsor:
University of California, San Francisco
Conditions:
Autism Spectrum Disorder
Eligibility:
All Genders
5-22 years
Phase:
PHASE2
Brief Summary
An open-label examination of changes in metabolites with use of micronutrients in children with autism spectrum disorder (ASD). Investigators will also measure behavioral measures monthly at school wi...
Detailed Description
Children enrolled in Oak Hill School will enroll in this study and take micronutrient supplement once a day for 8 weeks period. Behavioral measures and metabolites taken from Dried Blood Spots (DBS) w...
Eligibility Criteria
Inclusion
- Male or female, enrolled at Oak Hill School (OHS), age 6-22 and with a diagnosis of ASD.
- ASD diagnosis will be established by standard criteria (DSM-IV criteria and expert clinician review of medical records and child observation).
- Written informed consent obtained from the subject's legal representative and ability for subject to comply with the requirements of the study.
Exclusion
- Presence of a condition or abnormality that in the opinion of the Investigator would compromise the safety of the patient or the quality of the data.
- Taking multivitamins currently and unwilling to stop during the study period
Key Trial Info
Start Date :
November 14 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 30 2023
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT05268744
Start Date
November 14 2022
End Date
January 30 2023
Last Update
February 29 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, San Francisco
San Francisco, California, United States, 94143